KIELY WHITHAM: Open Payments
NPI 1730705252 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 8 payments from 8 companies in 2025. Trend: 2023 $625 · 2024 $224 · 2025 $190
Food & beverage: $190
| Company | Payments | Amount |
|---|---|---|
| Integra LifeSciences Corporation | 1 | $48 |
| Lilly USA, LLC | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| ABBVIE INC. | 1 | $22 |
| Genentech USA, Inc. | 1 | $18 |
| Impel Pharmaceuticals LLC | 1 | $15 |
| Avanos Medical | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: CODMAN CERTAS, AMYVID, KESIMPTA, UBRELVY, Ocrevus Zunovo, TRUDHESA, INITIAL PLACEMENT KITS, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
